Tuesday, April 10, 2012

Icahn Sues Amylin to Push for Sale; Amgen Pays $315M for KAI - Apr. 10, 2012

Having trouble viewing this email? View in Browser.
BioSpace GenePool
   Tuesday, April 10, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Your goals. Our expertise.

Norwich Clinical Services is a global contract research organization for the pharmaceutical and biotech industries. Dedicated Norwich program management will guide your program from the initial stages of development through study-end reconciliation with specific focus on budget efficiency and schedule adherence.

Please click here for more information.
Top Stories 
•  Icahn Sues Amylin Pharmaceuticals, Inc. (AMLN) to Push for Sale More...
•  Amgen (AMGN) Pays $315 Million for KAI Pharmaceuticals, Inc. More...
•  BioVentures Closes $268 Million Life Sciences Fund More...
•  Merck Teams With Flagship to Bankroll Biotech Start-ups More...
•  Affymax, Inc. (AFFY) Gets $50 Million Milestone in Anemia Deal With Takeda Pharmaceutical Co. Ltd. (TKDG.DE) More...
•  ViroPharma Incorporated (VPHM): FDA Denies Vancocin Petition, Approves Generic Rivals; Stock Falls -5.77(20.17%) @ 10:18AM EDT More...
•  VIVUS, Inc. (VVUS) Weight-Loss Drug Qnexa Gets Three-Month Delay for FDA Review More...
•  Oncothyreon Inc. (ONTY) Marches On With 'Son of Stimuvax' Cancer Vaccine More...
More Top News
Don't Miss This

The Pharmaceutical Compliance Forum (PCF) International Pharmaceutical Compliance Congress, www.InternationalPharmaCongress.com , May 14-16, 2012, takes place at the Hilton Budapest in Budapest, Hungary and features tracks on EU, CEE, MEA, global compliance audits and monitoring, FCPA and global anticorruption, global transparency, discourse and aggregate spend and global compliance case studies.

For more information, please visit: http://internationalpharmacongress.com/.
Featured Stories
•  Fish Oil: Is it Any Good for Us?, National Cancer Center Study More...
•  Aspirin Reduces Cancer Mortality Rate, American Cancer Society Reveals More...
•  Weill Cornell Medical College Researchers Find Genes Linked to Aggressive Prostate Cancer More...
•  Eye Tremors May Aid Early Diagnosis of Parkinson's, Hunter Holmes McGuire VA Medical Center Study More...
•  Feeling "Trapped," Obligated Raises Odds of Job Burnout, Concordia University Study More...
•  Stony Brook School of Medicine Study Links Toxic Component in Herbal Remedies to Kidney Failure and Cancer More...
•  Bullying Can Cause Social Stress in Monkeys, University of Chicago Study More...
•  Life Expectancy May Affect When You Get Married, Divorced, Have Kids, Queen's University Study More...
Tower: Facebook
  More Featured News
Event of the day

2012 Workshop on Protein Aggregation and Immunogenicity
July 9-12, 2012
Early Registration: $695 - $1,395

Aggregation of therapeutic proteins can occur during bioprocessing, shipping, storage and even delivery to the patient. Understanding of the roles of aggregates in immunogenicity of therapeutic protein products is critical. Such immune responses can have serious consequences for patients. Also, immunogenicity can be major stumbling blocks to product development and has even plagued licensed protein therapeutics. To increase understanding of the impact of protein aggregation on immunogenicity, the Workshop will focus on five central areas:

1) clinical aspects of immunogenicity to therapeutic proteins;
2) utility of animal models and in vitro cell assays for assessing immunogenicity of aggregates and particles;
3) causes and control of aggregates and particles in formulations;
4) causes and control of aggregates and particles during processing; and
5) insights and challenges with analytical methods.

Please note: The early registration fee expires May 1, 2012, and includes a buffet for breakfast and lunch each day, opening and closing receptions, and a workshop notebook.

To register and view the schedule of speakers by industry leader's visit our website.
Latest Market Insight

Advances in Ion Channel Drug Discovery

• Understand the competitive landscape in ion channel modulation and compare the pipelines of specialist companies operating in this area
• Identify the most promising targets from a "likelihood of success" viewpoint.
• Identify the targets with scope for ion channel intervention and major market opportunity.

Click Here for More Information.
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
Top Jobs
BioMidwest (Deerfield, Illinois)

Astellas Pharma US
Senior Medical Director / Executive Director, Infectious Disease
Serve as global medical lead (GML) on Astellas Pharma Global Development (APGD) Core teams, or may support global development as an extended team member. The Senior Director plays a key role in the design, conduct, analysis, and reporting of clinical trials including protocol development, evaluation of safety information from ongoing studies, data analysis and interpretation, and report writing.

Pharm Country (Parsippany, New Jersey)

Watson Pharmaceuticals, Inc.
Department Coordinator II
Maintains regulatory affairs objectives complementary to corporate policies and goals. Request documents and formats data from other departments in a comprehensive package as directed by supervisor for inclusion in submission. Supports maintenance of regulatory affairs information databases to track various statuses of projects.

Biotech Beach (La Jolla, California)

Pfizer Inc.
Director, Signal Transduction
Reports in to Head of Tumor Cell Biology (TCB). Interacts with Medicinal Chemistry group and scientists across Oncology Research Unit (ORU) organization. Direct supervision of lab leaders and scientists in the Signal Transduction group.

Genetown(Woburn, Massachusetts)

EMD Millipore
Research Scientist III
Will develop, transfer, and validate analytical methods to support Upstream Processing development projects such as chemically defined mammalian cell culture media. As such, the candidate will be expected to provide analytical leadership on project teams within the matrix organization and coordinate all analytical activities in support of product development.

BioCapital (Frederick, Maryland)

MedImmune, LLC
QA Specialist III
Responsible for assuring the quality of licensed products manufactured at MedImmune and contractors. Supports the evaluation and disposition of labeling, raw materials, intermediates and finished products through timely compliance evaluation of batch records, laboratory results and other cGMP documents.

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!
BioSpace Career Fairs

Biotech Beach

Biotech Beach Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California area.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Biotech Beach Career Fair, La Jolla, CA April 17, 2012
BioCapital Career Fair, Bethesda, MD April 25, 2012
Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Company of the day

Synageva BioPharma
Corporate Offices
128 Spring Street, Suite 520
Lexington, Massachusetts 02421 U.S.A
Phone: 781-890-1111 Fax: 781-890-1114

Synageva BioPharma is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.

More Company Profiles
Free Resources
FREE Subscription to BioPharm International

BioPharm International provides a forum for its readers to exchange practical, hands-on information for developing and manufacturing pharmaceutical products through biotechnology; and serves as a supportive, authoritative voice in the evolving business, regulatory, scientific, and technical areas of the biopharmaceutical industry.
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.



No comments: